Article
The use of antihistamine cetirizine during the first six weeks of nevirapine-containing antiretroviral treatment does not protect against nevirapine-associated cutaneous reactions, according to the results of a controlled study.
POLL: Are You Attending the 44th Annual Fall Clinical Dermatology Conference?
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Navigating Complexities and Unmet Needs of Chronic Hand Eczema
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Facing Challenges in Pediatric Plaque Psoriasis
Insights into the Association Between Pruritus and Liver Disease